Evidence map›Paper›PMID 23788502›Full record

ArticleCirculation research2013

Making steady progress on direct cardiac reprogramming toward clinical application.

Kenji Miki, Yoshinori Yoshida, Shinya Yamanaka

Abstract readComment
PubMed Publisher
In one paragraph

Article in Circulation research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Direct Reprogramming-The Future of Cardiac Regeneration?International journal of molecular sciences · 2015
    Review
  5. Review
  6. Review
  7. Reprogramming approaches in cardiovascular regeneration.Current treatment options in cardiovascular medicine · 2014
    Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Kenji MikiCenter for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
Yoshinori Yoshida
Shinya Yamanaka

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new report demonstrates direct cardiac reprogramming in human cells for the first time and points to the possibility of moving this technology toward clinical applications.

Indexed as

PhenotypeCell TransdifferentiationFibroblastsGene Expression RegulationHumansMyocytes, Cardiac

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.